Hemodialysis patients have a high cardiovascular mortality and hypertension is the most prevalent treatable risk factor. Hemodialysis is an unphysiological therapy respect to daily renal function, and the approach to avoid the related may be to increase dialysis frequency using a daily dialysis therapy. We analyze as the effect of more long or frequent weekly dialysis can improve the hypertension in hemodialysis patients
Chronic Kidney disease (CKD) patients, particularly those with end stage renal disease (ESRD), are a...
The National Institutes of Health (NIH) sponsored HEMO Study did not demonstrate that an increase in...
Cardiovascular disease remains the most common cause of mortality in patients with end-stage kidney ...
Hemodialysis patients have a high cardiovascular mortality and hypertension is the most prevalent tr...
Hemodialysis patients have a high cardiovascular mortality and hypertension is the most prevalent tr...
Hemodialysis patients have a high cardiovascular mortality and hypertension is the most prevalent tr...
Hemodialysis patients have a high cardiovascular mortality and hypertension is the most prevalent tr...
Clinical and biochemical correlates of starting “daily” hemodialysis.BackgroundDaily hemodialysis ha...
Cardiovascular complications are the most prominent causes of morbidity and mortality among chronic ...
Hypertension and survival in chronic hemodialysis patients—Past lessons and future opportunities. Th...
Treatment of end stage renal disease patients with short daily hemodialysis has been associated with...
Treatment of end stage renal disease patients with short daily hemodialysis has been associated with...
<div><p>Background</p><p>Treatment of end stage renal disease patients with short daily hemodialysis...
Previous observational studies had suggested that the high mortality and morbidity of ESRD patients ...
Background: Treatment of end stage renal disease patients with short daily hemodialysis has been ...
Chronic Kidney disease (CKD) patients, particularly those with end stage renal disease (ESRD), are a...
The National Institutes of Health (NIH) sponsored HEMO Study did not demonstrate that an increase in...
Cardiovascular disease remains the most common cause of mortality in patients with end-stage kidney ...
Hemodialysis patients have a high cardiovascular mortality and hypertension is the most prevalent tr...
Hemodialysis patients have a high cardiovascular mortality and hypertension is the most prevalent tr...
Hemodialysis patients have a high cardiovascular mortality and hypertension is the most prevalent tr...
Hemodialysis patients have a high cardiovascular mortality and hypertension is the most prevalent tr...
Clinical and biochemical correlates of starting “daily” hemodialysis.BackgroundDaily hemodialysis ha...
Cardiovascular complications are the most prominent causes of morbidity and mortality among chronic ...
Hypertension and survival in chronic hemodialysis patients—Past lessons and future opportunities. Th...
Treatment of end stage renal disease patients with short daily hemodialysis has been associated with...
Treatment of end stage renal disease patients with short daily hemodialysis has been associated with...
<div><p>Background</p><p>Treatment of end stage renal disease patients with short daily hemodialysis...
Previous observational studies had suggested that the high mortality and morbidity of ESRD patients ...
Background: Treatment of end stage renal disease patients with short daily hemodialysis has been ...
Chronic Kidney disease (CKD) patients, particularly those with end stage renal disease (ESRD), are a...
The National Institutes of Health (NIH) sponsored HEMO Study did not demonstrate that an increase in...
Cardiovascular disease remains the most common cause of mortality in patients with end-stage kidney ...